|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 October 2017 |
|
Main ID: |
NCT00615472 |
|
Date of registration:
|
09/01/2008 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Intravenous Versus Inhalational Anesthesia in Parkinson's Disease
|
|
Scientific title:
|
Intravenous General Anesthesia Versus Inhalational General Anesthesia in Parkinson's Disease |
|
Date of first enrolment:
|
October 2003 |
|
Target sample size:
|
58 |
|
Recruitment status: |
Terminated |
|
URL:
|
https://clinicaltrials.gov/show/NCT00615472 |
|
Study type:
|
Interventional |
|
Study design:
|
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Eric J Heyer, M.D., Ph.D. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Columbia University |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Clinical diagnosis of Parkinson's Disease with bilateral deep brain stimulation
surgery indicated as treatment
Exclusion Criteria:
- Not fluent in English
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Parkinson's Disease
|
|
Intervention(s)
|
|
Drug: Isoflurane
|
|
Drug: Propofol
|
|
Drug: Remifentanil
|
|
Primary Outcome(s)
|
|
Number of Participants With Improved Postoperative Delirium and Cognitive and Motor Changes
[Time Frame: Four months]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|